1PZI
Heat-Labile Enterotoxin B-Pentamer Complexed With Nitrophenyl Galactoside 2a
1PZI の概要
| エントリーDOI | 10.2210/pdb1pzi/pdb |
| 関連するPDBエントリー | 1PZJ 1PZK |
| 分子名称 | Heat-labile Enterotoxin B subunit, N-(2-MORPHOLIN-4-YL-1-MORPHOLIN-4-YLMETHYL-ETHYL)-3-NITRO-5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-BENZAMIDE (3 entities in total) |
| 機能のキーワード | pentamer, monovalent, toxin, inhibitor, toxin inhibitor |
| 由来する生物種 | Escherichia coli |
| タンパク質・核酸の鎖数 | 5 |
| 化学式量合計 | 61820.51 |
| 構造登録者 | Mitchell, D.D.,Pickens, J.C.,Korotkov, K.,Fan, E.,Hol, W.G.J. (登録日: 2003-07-11, 公開日: 2004-03-09, 最終更新日: 2024-10-16) |
| 主引用文献 | Mitchell, D.D.,Pickens, J.C.,Korotkov, K.,Fan, E.,Hol, W.G.J. 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies Bioorg.Med.Chem., 12:907-920, 2004 Cited by PubMed Abstract: With the aim of developing high-affinity mono and multivalent antagonists of cholera toxin (CT) and Escherichia coli heat-labile enterotoxin (LT) we are using the galactose portion of the natural receptor ganglioside GM1 as an anchoring fragment in structure-based inhibitor design efforts. In order to establish a better structure-activity relationship for guiding these studies, we designed and prepared a small focused library of twenty 3,5-substituted phenylgalactosides based on two previous leads. The compounds were tested for their ability to block CTB(5) binding to immobilized ganglioside receptor and compared to the two previous leads. The crystal structures of the most promising compounds bound to either CTB(5) or LTB(5) were then determined in order to understand the basis for affinity differences. The most potent new compound yielded a six-fold improvement over our benchmark lead m-nitrophenyl-alpha-d-galactopyranoside (MNPG), and a two-fold improvement in IC(50) over a newer MNPG derivative. These results support the notion that the m-nitrophenyl moiety of MNPG and its derivatives is an important element to retain in future optimization efforts. Additionally, a consensus binding-pocket for the alkylmorpholine or piperazine moiety present in all of the designed antagonists was established as an important area of the GM1 binding site to target in future work. PubMed: 14980603DOI: 10.1016/j.bmc.2003.12.019 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.99 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






